Align Technology (ALGN) and The Competition Critical Analysis
Align Technology (NASDAQ: ALGN) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its peers? We will compare Align Technology to related companies based on the strength of its earnings, risk, profitability, institutional ownership, dividends, valuation and analyst recommendations.
Valuation and Earnings
This table compares Align Technology and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Align Technology||$1.24 billion||$306.55 million||65.88|
|Align Technology Competitors||$827.23 million||$159.49 million||36.37|
Align Technology has higher revenue and earnings than its peers. Align Technology is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Volatility & Risk
Align Technology has a beta of 1.54, indicating that its share price is 54% more volatile than the S&P 500. Comparatively, Align Technology’s peers have a beta of 1.06, indicating that their average share price is 6% more volatile than the S&P 500.
This is a breakdown of recent ratings and price targets for Align Technology and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Align Technology Competitors||171||1123||2462||89||2.64|
Align Technology presently has a consensus target price of $193.20, suggesting a potential upside of 0.43%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 9.81%. Given Align Technology’s peers higher probable upside, analysts plainly believe Align Technology has less favorable growth aspects than its peers.
Insider & Institutional Ownership
81.6% of Align Technology shares are owned by institutional investors. Comparatively, 63.1% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 1.6% of Align Technology shares are owned by company insiders. Comparatively, 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
This table compares Align Technology and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Align Technology Competitors||-127.07%||-36.30%||-10.21%|
Align Technology beats its peers on 10 of the 13 factors compared.
About Align Technology
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.